The reciprocal risks of stroke and cognitive impairment in an elderly population

Alzheimer's and Dementia

Volumn 2, Issue 3, 2006, Pages 171-178

  Jin, Ya Ping ^a   Di Legge, Silvia ^a   Ostbye, Truls ^b   Feightner, John W ^a   Hachinski, Vladimir ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aging; Cognitive impairment no dementia; Dementia; Incidence; Prevalence; Stroke

Indexed keywords

AGE DISTRIBUTION; AGED; ARTICLE; CANADA; CLINICAL EXAMINATION; COGNITIVE DEFECT; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; FREQUENCY ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; SCORING SYSTEM; SENILE DEMENTIA; STANDARDIZATION; STROKE;

EID: 33744935024     PISSN: 15525260     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jalz.2006.03.006     Document Type: Article

References (45)

1. Thurman R.J., and Jauch E.C. Acute ischemic stroke. emergent evaluation and management. Emerg Med Clin North Am 2 (2002) 609-630
2. Gwyther L.P. Social issues of the Alzheimer's patient and family. Am J Med 104 (1998) 17S-21S
3. Tatemichi T.K., Desmond D.W., Mayeux R., Paik M., Stern Y., Sano M., et al. Dementia after stroke. Baseline frequency, risks, and clinical features in a hospitalized cohort. Neurology 42 (1992) 1185-1193
4. Zhu L., Fratiglioni L., Guo Z., Aguero-Torres H., Winblad B., and Viitanen M. Association of stroke with dementia, cognitive impairment, and functional disability in the very old. A population-based study. Stroke 29 (1998) 2094-2099
5. Linden T., Skoog I., Fagerberg B., Steen B., and Blomstrand C. Cognitive impairment and dementia 20 months after stroke. Neuroepidemiology 23 1-2 (2004) 45-52
6. Fiebach N.H., Hebert P.R., Stampfer M.J., Colditz G.A., Willett W.C., Rosner B., et al. A prospective study of high blood pressure and cardiovascular disease in women. Am J Epidemiol 130 4 (1989) 646-654
7. Launer L.J., Ross G.W., Petrovitch H., Masaki K., Foley D., White L.R., et al. Midlife blood pressure and dementia. The Honolulu-Asia aging study. Neurobiol Aging 21 1 (2000) 49-55
8. Peng D.Q., Zhao S.P., and Wang J.L. Lipoprotein (a) and apolipoprotein E epsilon 4 as independent risk factors for ischemic stroke. J Cardiovasc Risk 6 1 (1999) 1-6
9. Hsiung G.Y., Sadovnick A.D., and Feldman H. Apolipoprotein E epsilon4 genotype as a risk factor for cognitive decline and dementia. data from the Canadian Study of Health and Aging. CMAJ 171 8 (2004) 863-867
10. Kiely D.K., Wolf P.A., Cupples L.A., Beiser A.S., and Kannel W.B. Physical activity and stroke risk. the Framingham Study. Am J Epidemiol 140 7 (1994) 608-620
11. Laurin D., Verreault R., Lindsay J., MacPherson K., and Rockwood K. Physical activity and risk of cognitive impairment and dementia in elderly persons. Arch Neurol 58 3 (2001) 498-504
12. Ritchie K., Artero S., and Touchon J. Classification criteria for mild cognitive impairment. a population-based validation study. Neurology 56 1 (2001) 37-42
13. Palmer K., Wang H.X., Backman L., Winblad B., and Fratiglioni L. Differential evolution of cognitive impairment in nondemented older persons. Results from the Kungsholmen Project. Am J Psychiatry 159 3 (2002) 436-442
14. Morris J.C., Storandt M., Miller J.P., McKeel D.W., Price J.L., Rubin E.H., et al. Mild cognitive impairment represents early-stage Alzheimer disease. Arch Neurol 58 3 (2001) 397-405
15. Tuokko H., Frerichs R., Graham J., Rockwood K., Kristjansson B., Fisk J., et al. Five-year follow-up of cognitive impairment with no dementia. Arch Neurol 60 4 (2003) 577-582
16. Spiers N.A., Jagger C., Matthews F.E., Boult C., Robinson T.G., and Brayne C. Diseases and impairments as risk factors for onset of disability in the older population in England and Wales. Findings from the Medical Research Council Cognitive Function and Ageing Study. MR. J Gerontol A Biol Sci Med Sci 60 2 (2005) 248-254
17. Brown R.D., Whisnant J.P., Sicks J.D., O'Fallon W.M., and Wiebers D.O. Stroke incidence, prevalence, and survival. Secular trends in Rochester, Minnesota, through 1989. Stroke 27 3 (1996) 373-380
18. Saposnik G., Del Brutto O.H., and Iberoamerican Society of Cerebrovascular Diseases. Stroke in South America. A systematic review of incidence, prevalence, and stroke subtypes. Stroke 34 9 (2003) 2103-2107
19. The Canadian Study of Health and Aging Working Group. Canadian study of health and aging. Study methods and prevalence of dementia. CMAJ 150 6 (1994) 899-913
20. Graham J.E., Rockwood K., Beattie B.L., Eastwood R., Gauthier S., Tuokko H., et al. Prevalence and severity of cognitive impairment with and without dementia in an elderly population. Lancet 349 9068 (1997) 1793-1796
21. Unverzagt F.W., Gao S., Baiyewu O., Ogunniyi A.O., Gureje O., Perkins A., et al. Prevalence of cognitive impairment. data from the Indianapolis Study of Health and Aging. Neurology 57 9 (2001) 1655-1662
22. Seshadri S., Beiser A., Kelly-Hayes M., Kase C.S., Au R., Kannel W.B., et al. The lifetime risk of stroke. Estimates from the Framingham Study. Stroke 37 2 (2006) 345-350
23. Honig L.S., Tang M.X., Albert S., Costa R., Luchsinger J., Manly J., et al. Stroke and the risk of Alzheimer disease. Arch Neurol 60 12 (2003) 1707-1712
24. Ivan C.S., Seshadri S., Beiser A., Au R., Kase C.S., Kelly-Hayes M., et al. Dementia after stroke. The Framingham Study. Stroke 35 6 (2004) 1264-1268
25. Kokmen E., Whisnant J.P., O'Fallon W.M., Chu C.P., and Beard C.M. Dementia after ischemic stroke. A population-based study in Rochester, Minnesota (1960-1984). Neurology 46 1 (1996) 154-159
26. Ferrucci L., Guralnik J.M., Salive M.E., Pahor M., Corti M.C., Baroni A., et al. Cognitive impairment and risk of stroke in the older population. J Am Geriatr Soc 44 3 (1996) 237-241
27. Zhu L., Fratiglioni L., Guo Z., Winblad B., and Viitanen M. Incidence of stroke in relation to cognitive function and dementia in the Kungsholmen Project. Neurology 54 11 (2000) 2103-2107
28. de Moraes S.A., Szklo M., Tilling K., Sato R., and Knopman D. Cognitive functioning as a predictor of ischemic stroke incidence. Epidemiology 14 6 (2003) 673-679
29. The Canadian Study of Health and Aging Working Group, and The Canadian Study of Health and Aging Working Group. The incidence of dementia in Canada. Neurology 55 1 (2000) 66-73
30. Teng E.L., and Chui H.C. The Modified Mini-Mental State (3MS) examination. J Clin Psychiatry 48 8 (1987) 314-318
31. Eastwood R., Nobbs H., Lindsay J., et al. Canadian Study of Health and Aging. Dementia 3 (1992) 209-212
32. Bland R.C., and Newman S.C. Mild dementia or cognitive impairment. The Modified Mini-Mental State examination (3MS) as a screen for dementia. Can J Psychiatry 46 6 (2001) 506-510
33. McDowell I., Hill G., and Lindsay J. An overview of the Canadian Study of Health and Aging. Int Psychogeriatr 13 Supp 1 (2001) 7-18
34. Tuokko H., Kristjansson E., and Miller J. Neuropsychological detection of dementia. An overview of the neuropsychological component of the Canadian Study of Health and Aging. J Clin Exp Neuropsychol 17 3 (1995) 352-373
35. Association A.P. Diagnostic and Statistical Manual of Mental Disorders. 3rd ed revised (1987), American Psychiatric Association, Washington, DC
36. Morris J.A., and Gardner M.J. Epidemiological studies. In: Altman D.G., Machin D., Bryant T.N., and Cardner M.J. (Eds). Statistics with Confidence. 2nd ed. (2000), J W Arrowsmith Ltd, Bristol 70-71
37. Prencipe M., Santini M., Casini A.R., Pezzella F.R., Scaldaferri N., and Culasso F. Prevalence of non-dementing cognitive disturbances and their association with vascular risk factors in an elderly population. J Neurol 250 8 (2003) 907-912
38. Leys D., Henon H., Mackowiak-Cordoliani M.A., and Pasquier F. Poststroke dementia. Lancet Neurol 4 11 (2005) 752-759
39. Desmond D.W., Moroney J.T., Sano M., and Stern Y. Incidence of dementia after ischemic stroke. Results of a longitudinal study. Stroke 33 9 (2002) 2254-2260
40. Salas M., In't Veld B.A., van der Linden P.D., Hofman A., Breteler M., and Stricker B.H. Impaired cognitive function and compliance with antihypertensive drugs in elderly. The Rotterdam Study. Clin Pharmacol Ther 70 6 (2001) 561-566
41. Rodriguez E.G., Dodge H.H., Birzescu M.A., Stoehr G.P., and Ganguli M. Use of lipid-lowering drugs in older adults with and without dementia. A community-based epidemiological study. J Am Geriatr Soc 50 11 (2002) 1852-1856
42. Abel Latif A.K., Peng X., and Messinger-Rapport B.J. Predictors of anticoagulation prescription in nursing home residents with atrial fibrillation. J Am Med Dir Assoc 6 2 (2005) 128-131
43. O'Mahony P.G., Dobson R., Rodgers H., James O.F., and Thomson R.G. Validation of a population screening questionnaire to assess prevalence of stroke. Stroke 26 8 (1995) 1334-1337
44. Fratiglioni L., Viitanen M., von Strauss E., Tontodonati V., Herlitz A., and Winblad B. Very old women at highest risk of dementia and Alzheimer's disease. Incidence data from the Kungsholmen Project, Stockholm. Neurology 48 1 (1997) 132-138
45. Hachinski V. Preventable senility. A call for action against the vascular dementias. Lancet 340 8820 (1992) 645-648